Francesca Sironi
Overview
Explore the profile of Francesca Sironi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
891
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Parolini F, Biswas P, Serena M, Sironi F, Muraro V, Guizzardi E, et al.
J Virol
. 2018 Aug;
92(17).
PMID: 30115775
No abstract available.
12.
Zhang P, Gorman J, Geng H, Liu Q, Lin Y, Tsybovsky Y, et al.
Cell Host Microbe
. 2018 Jun;
23(6):832-844.e6.
PMID: 29902444
The HIV-1 envelope (Env) spike is a trimer of gp120/gp41 heterodimers that mediates viral entry. Binding to CD4 on the host cell membrane is the first essential step for infection...
13.
Serena M, Parolini F, Biswas P, Sironi F, Miranda A, Zoratti E, et al.
Sci Rep
. 2018 May;
8:46991.
PMID: 29786690
This corrects the article DOI: 10.1038/srep40037.
14.
Vallarola A, Sironi F, Tortarolo M, Gatto N, De Gioia R, Pasetto L, et al.
J Neuroinflammation
. 2018 Mar;
15(1):65.
PMID: 29495962
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects the motor neuromuscular system leading to complete paralysis and premature death. The multifactorial nature of ALS that involves...
15.
Sironi F, Vallarola A, Violatto M, Talamini L, Freschi M, De Gioia R, et al.
Stem Cell Res
. 2017 Nov;
25:166-178.
PMID: 29154076
Stem cell therapy is considered a promising approach in the treatment of amyotrophic lateral sclerosis (ALS) and mesenchymal stem cells (MSCs) seem to be the most effective in ALS animal...
16.
Parolini F, Biswas P, Serena M, Sironi F, Muraro V, Guizzardi E, et al.
J Virol
. 2017 Oct;
92(1).
PMID: 29070683
HLA-C expression is associated with a differential ability to control HIV-1 infection. Higher HLA-C levels may lead to better control of HIV-1 infection through both a higher efficiency of antigen...
17.
Malnati M, Ugolotti E, Monti M, De Battista D, Vanni I, Bordo D, et al.
Sci Rep
. 2017 Feb;
7:42470.
PMID: 28211903
Several studies demonstrated a relevant role of polymorphisms located within the HLA-B and -C loci and the Killer Immunoglobulin Receptors (KIRs) 3DL1 and 3DS1 in controlling HIV-1 replication. KIRs are...
18.
Serena M, Parolini F, Biswas P, Sironi F, Miranda A, Zoratti E, et al.
Sci Rep
. 2017 Jan;
7:40037.
PMID: 28051183
HLA-C has been demonstrated to associate with HIV-1 envelope glycoprotein (Env). Virions lacking HLA-C have reduced infectivity and increased susceptibility to neutralizing antibodies. Like all others MHC-I molecules, HLA-C requires...
19.
Sironi F, Malnati M, Mongelli N, Cozzi P, Guzzo C, Ghezzi S, et al.
J Transl Med
. 2015 Apr;
13:107.
PMID: 25888743
Background: Combined antiretroviral therapy has drastically reduced mortality and morbidity of HIV-infected individuals. Nevertheless long-term toxicity and appearance of viral resistance hampers the prolonged effectiveness of combination therapy, requiring a...
20.
Sironi F, Primignani P, Ricca S, Tunesi S, Zini M, Tesei S, et al.
Neurosci Lett
. 2013 Nov;
557 Pt B:165-70.
PMID: 24176883
We analyzed the DJ1 gene in a large consecutive series (N=163) of Italian unrelated Early Onset Parkinson Disease (EOPD: onset ≤40 years of age) patients and 100 healthy controls (mean...